Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 17.1T | 15.2T | 15.7T | 16.2T |
Cost of revenue | 6.4T | 5.7T | 6.3T | 6.4T |
Gross profit | 10.7T | 9.5T | 9.5T | 9.8T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 4.7T | 4.4T | 2.7T | 2.8T |
Other operating expenses | 38.2B | 15.0B | 2.9T | 2.2T |
Operating income | 5.9T | 5.1T | 3.9T | 4.8T |
Non operating interest income | ||||
Income | 256.4B | 245.5B | 278.3B | 358.7B |
Expense | 607.0B | 527.9B | 587.9B | 579.7B |
Other income expense | 1.0T | 744.7B | 229.2B | 35.5B |
Pretax income | 6.5T | 5.5T | 3.8T | 4.6T |
Tax provision | 1.4T | 984.8B | 808.9B | 722.9B |
Net income | 5.2T | 4.5T | 3.0T | 3.9T |
Basic EPS | 4.5 | 3.9 | 2.6 | 3.3 |
Diluted EPS | 4.4 | 3.9 | 2.6 | 3.3 |
Basic average shares | 1.2T | 1.2T | 1.2T | 1.2T |
Diluted average shares | 1.2T | 1.2T | 1.2T | 1.2T |
EBITDA | 7.3T | 6.1T | 5.1T | 6.2T |
Net income from continuing op. | 5.2T | 4.5T | 3.0T | 3.9T |
Minority interests | 9.5B | -6.8B | -24.6B | -2.7B |
Preferred stock dividends | — | — | — | — |